The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Type 1 diabetes as a relapsing–remitting disease?
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Salomon, B., Lenschow, D. J., Rhee, L., Ashourian, N., Singh, B., Sharpe, A., & Bluestone, J. A. (2000) · Immunity · doi:10.1016/s1074-7613(00)80195-8 · Cited by 2,081
In Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune Diabetes
Tang, Q., Henriksen, K. J., Bi, M., Finger, E. B., Szot, G., Ye, J., Masteller, E. L., McDevitt, H., Bonyhadi, M., & Bluestone, J. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040139 · Cited by 1,221
Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes
Keymeulen, B., Vandemeulebroucke, E., Ziegler, A. G., Mathieu, C., Kaufman, L., Hale, G., Gorus, F., Goldman, M., Walter, M., Candon, S., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043980 · Cited by 1,099
Defective Suppressor Function in CD4+CD25+ T-Cells From Patients With Type 1 Diabetes
Lindley, S., Dayan, C. M., Bishop, A., Roep, B. O., Peakman, M., & Tree, T. I. M. (2005) · Diabetes · doi:10.2337/diabetes.54.1.92 · Cited by 861
Effects of insulin in relatives of patients with type 1 diabetes mellitus
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012350 · Cited by 836
Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice
Tang, Q., Adams, J. Y., Tooley, A. J., Bi, M., Fife, B. T., Serra, P., Santamaria, P., Locksley, R. M., Krummel, M. F., & Bluestone, J. A. (2006) · Nature Immunology · doi:10.1038/ni1289 · Cited by 774
Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice
Nakayama, M., Abiru, N., Moriyama, H., Babaya, N., Liu, E., Miao, D., Yu, L., Wegmann, D. R., Hutton, J. C., Elliott, J. F., et al. (2005) · Nature · doi:10.1038/nature03523 · Cited by 758
Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis
McMahon, E. J., Bailey, S. L., Castenada, C. V., Waldner, H., & Miller, S. D. (2005) · Nature Medicine · doi:10.1038/nm1202 · Cited by 694
Effects of Oral Insulin in Relatives of Patients With Type 1 Diabetes
The Diabetes Prevention Trial-Type 1 Study Group (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1068 · Cited by 668
Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice.
Chatenoud, L., Thervet, E., Primo, J., & Bach, J. F. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.1.123 · Cited by 664
Herold, K. C., Gitelman, S. E., Masharani, U., Hagopian, W., Bisikirska, B., Donaldson, D., Rother, K., Diamond, B., Harlan, D. M., & Bluestone, J. A. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1763 · Cited by 634
Self-citationBelghith, M., Bluestone, J. A., Barriot, S., Mégret, J., Bach, J.-F., & Chatenoud, L. (2003) · Nature Medicine · doi:10.1038/nm924 · Cited by 586
Dotta, F., Censini, S., van Halteren, A. G. S., Marselli, L., Masini, M., Dionisi, S., Mosca, F., Boggi, U., Muda, A. O., Prato, S. D., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700442104 · Cited by 569
(1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-7-199804010-00001 · Cited by 546
Raz, I., Elias, D., Avron, A., Tamir, M., Metzger, M., & Cohen, I. R. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06801-5 · Cited by 508
Palmer, J. P., Fleming, G. A., Greenbaum, C. J., Herold, K. C., Jansa, L. D., Kolb, H., Lachin, J. M., Polonsky, K. S., Pozzilli, P., Skyler, J. S., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.1.250 · Cited by 491
Self-citationArif, S., Tree, T. I., Astill, T. P., Tremble, J. M., Bishop, A. J., Dayan, C. M., Roep, B. O., & Peakman, M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19585 · Cited by 479
Determinant spreading and the dynamics of the autoimmune T-cell repertoire
Lehmann, P. V., Sercarz, E. E., Forsthuber, T., Dayan, C. M., & Gammon, G. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90163-f · Cited by 461
Green, E. A., Gorelik, L., McGregor, C. M., Tran, E. H., & Flavell, R. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834400100 · Cited by 446
Peng, Y., Laouar, Y., Li, M. O., Green, E. A., & Flavell, R. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400810101 · Cited by 416
Kent, S. C., Chen, Y., Bregoli, L., Clemmings, S. M., Kenyon, N. S., Ricordi, C., Hering, B. J., & Hafler, D. A. (2005) · Nature · doi:10.1038/nature03625 · Cited by 409
Campbell, I. L., Kay, T. W., Oxbrow, L., & Harrison, L. C. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115055 · Cited by 374
Insulin-induced remission in new-onset NOD mice is maintained by the PD-1–PD-L1 pathway
Fife, B. T., Guleria, I., Gubbels Bupp, M., Eagar, T. N., Tang, Q., Bour-Jordan, H., Yagita, H., Azuma, M., Sayegh, M. H., & Bluestone, J. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061577 · Cited by 325
Citrullination is an inflammation-dependent process
Makrygiannakis, D., af Klint, E., Lundberg, I. E., Löfberg, R., Ulfgren, A.-K., Klareskog, L., & Catrina, A. I. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.049403 · Cited by 301
Bresson, D. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27191 · Cited by 293
Use of Inhaled Insulin in a Basal/Bolus Insulin Regimen in Type 1 Diabetic Subjects
Skyler, J. S., Weinstock, R. S., Raskin, P., Yale, J.-F., Barrett, E., Gerich, J. E., Gerstein, H. C., & the Inhaled Insulin Phase III Type 1 Diabetes Study Group (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1630 · Cited by 269
Yu, M., Johnson, J. M., & Tuohy, V. K. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1777 · Cited by 266
Natural History of Type 1 Diabetes
Achenbach, P., Bonifacio, E., Koczwara, K., & Ziegler, A.-G. (2005) · Diabetes · doi:10.2337/diabetes.54.suppl_2.s25 · Cited by 249
Lundberg, K., Nijenhuis, S., Vossenaar, E. R., Palmblad, K., van Venrooij, W. J., Klareskog, L., Zendman, A., & Harris, H. E. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1697 · Cited by 244
Clinical evidence for the safety of GAD65 immunomodulation in adult-onset autoimmune diabetes
Agardh, C.-D., Cilio, C. M., Lethagen, Å., Lynch, K., Leslie, R. D. G., Palmér, M., Harris, R. A., Robertson, J. A., & Lernmark, Å. (2005) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2004.12.003 · Cited by 226
Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP
Krishnamurthy, B., Dudek, N. L., McKenzie, M. D., Purcell, A. W., Brooks, A. G., Gellert, S., Colman, P. G., Harrison, L. C., Lew, A. M., Thomas, H. E., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29602 · Cited by 223
Kaniuk, N. A., Kiraly, M., Bates, H., Vranic, M., Volchuk, A., & Brumell, J. H. (2007) · Diabetes · doi:10.2337/db06-1160 · Cited by 223
Antiislet autoantibodies usually develop sequentially rather than simultaneously
Yu, L. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.12.4264 · Cited by 214
Sreenan, S., Pick, A. J., Levisetti, M., Baldwin, A. C., Pugh, W., & Polonsky, K. S. (1999) · Diabetes · doi:10.2337/diabetes.48.5.989 · Cited by 193
beta-cell apoptosis and defense mechanisms: lessons from type 1 diabetes.
Eizirik, D. L., & Darville, M. I. (2001) · Diabetes · doi:10.2337/diabetes.50.2007.s64 · Cited by 176
Sherry, N. A., Chen, W., Kushner, J. A., Glandt, M., Tang, Q., Tsai, S., Santamaria, P., Bluestone, J. A., Brillantes, A.-M. B., & Herold, K. C. (2007) · Endocrinology · doi:10.1210/en.2007-0358 · Cited by 169
Self-citationCure of Overt Diabetes in NOD Mice by Transient Treatment With Anti-Lymphocyte Serum and Exendin-4
Ogawa, N., List, J. F., Habener, J. F., & Maki, T. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1700 · Cited by 155
Effects of Autoimmunity and Immune Therapy on β-Cell Turnover in Type 1 Diabetes
Sherry, N., Kushner, J. A., Glandt, M., Kitamura, T., Brillantes, A.-M. B., & Herold, K. C. (2006) · Diabetes · doi:10.2337/db05-1034 · Cited by 152
Self-citationBonifacio, E. E., Scirpoli, M., Kredel, K., Füchtenbusch, M., & Ziegler, A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.1.525 · Cited by 124
Posttranslational Modifications of Self‐Antigens
Doyle, H. A., & Mamula, M. J. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1313.001 · Cited by 109
Viral infections and cell cycle G2/M regulation
Zhao, Y., & Elder, R. T. (2005) · Cell Research · doi:10.1038/sj.cr.7290279 · Cited by 103
Analysis of T-Cell Assays to Measure Autoimmune Responses in Subjects With Type 1 Diabetes
Seyfert‐Margolis, V., Gisler, T. D., Asare, A. L., Wang, R. S., Dosch, H., Brooks‐Worrell, B., Eisenbarth, G. S., Palmer, J. P., Greenbaum, C. J., Gitelman, S. E., et al. (2006) · Diabetes · doi:10.2337/db05-1378 · Cited by 88
Self-citationRedefining the clinical remission period in children with type 1 diabetes
Chase, H. P., MacKenzie, T. A., Burdick, J., Fiallo-Scharer, R. V., Walravens, P., KLINGENSMITH, G. J., & Rewers, M. (2004) · Pediatric Diabetes · doi:10.1111/j.1399-543x.2004.00034.x · Cited by 87
Böber, E., Dündar, Β., & Büyükgebiz, A. (2001) · Journal of Pediatric Endocrinology & Metabolism (JPEM) · doi:10.1515/jpem.2001.14.4.435 · Cited by 82
Driver Clones and Determinant Spreading
Sercarz, E. E. (2000) · Journal of Autoimmunity · doi:10.1006/jaut.2000.0380 · Cited by 81
Eizirik, D. L. (1988) · European Journal of Endocrinology · doi:10.1530/acta.0.1190321 · Cited by 78
Imagawa, A., Hanafusa, T., Itoh, N., Waguri, M., Yamamoto, K., Miyagawa, J.-I., Moriwaki, M., Yamagata, K., Iwahashi, H., Sada, M., et al. (1999) · Diabetologia · doi:10.1007/s001250051197 · Cited by 57
Central and peripheral autoantigen presentation in immune tolerance
Pugliese, A. (2004) · Immunology · doi:10.1111/j.0019-2805.2003.01804.x · Cited by 56
Identification of Children with Early Onset and High Incidence of Anti-islet Autoantibodies
Robles, D. T., Eisenbarth, G. S., Wang, T., Erlich, H. A., Bugawan, T. L., Babu, S. R., Barriga, K., Norris, J. M., Hoffman, M., KLINGENSMITH, G. J., et al. (2002) · Clinical Immunology · doi:10.1006/clim.2001.5171 · Cited by 55
Partial remission phase of diabetes in children younger than age 10 years
Muhammad, B., Swift, P. G. F., Raymond, N. T., & Botha, J. L. (1999) · Archives of Disease in Childhood · doi:10.1136/adc.80.4.367 · Cited by 55
Cited by
Atkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60591-7 · Cited by 2,931
Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies
Van Belle, T. L., Coppieters, K. T., & Von Herrath, M. G. (2011) · Physiological Reviews · doi:10.1152/physrev.00003.2010 · Cited by 1,022
Regulation of Insulin Synthesis and Secretion and Pancreatic Beta-Cell Dysfunction in Diabetes
Fu, Z., R. Gilbert, E., & Liu, D. (2013) · Current Diabetes Reviews · doi:10.2174/157339913804143225 · Cited by 732
Environmental risk factors for type 1 diabetes
Rewers, M., & Ludvigsson, J. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30507-4 · Cited by 676
Orban, T., Bundy, B., Becker, D. J., DiMeglio, L. A., Gitelman, S. E., Goland, R., Gottlieb, P. A., Greenbaum, C. J., Marks, J. B., Monzavi, R., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60886-6 · Cited by 612
Metadata
- Authors
- von Herrath, M., Sanda, S., & Herold, K.
- Venue
- Nature Reviews Immunology
- Published
- 2007-12
- Volume
- 7
- Issue
- 12
- Pages
- 988-994
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W1984860462
- Cited by
- 270
- References
- 50
- FWCI
- 1.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.